DexCom, Inc. Profile Avatar - Palmy Investing

DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, a…
Medical - Devices
US, San Diego [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-39.00 -42.00 -30.00 -33.00 2.00 23.00 49.00 56.00 92.00 123.00 314.00 475.00 442.00 669.00 748.00
Operating Cash (Net)
-39.00 -42.00 -30.00 -33.00 2.00 23.00 49.00 56.00 92.00 123.00 314.00 475.00 442.00 669.00 748.00
Accounts Receivable
-2.00 -3.00 -5.00 -7.00 -6.00 -16.00 -31.00 -27.00 -31.00 -93.00 -60.00 -142.00 -75.00 -199.00 -260.00
Accounts Payable
1.00 - - - - - - 2.00 8.00 17.00 21.00 21.00 56.00 109.00 194.00 58.00 295.00 466.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-14.00 -25.00 -46.00 28.00 20.00 -16.00 -51.00 -55.00 -144.00 -139.00 -1,015.00 -1,018.00 -216.00 -521.00 -507.00
Capital Expenditure
-2.00 -6.00 -8.00 -9.00 -7.00 -16.00 -33.00 -55.00 -66.00 -67.00 -180.00 -199.00 -389.00 -364.00 -236.00
Purchases of Investments
-65.00 -73.00 -102.00 -66.00 -16.00 -13.00 -45.00 -39.00 -171.00 -453.00 -2,031.00 -3,058.00 -2,473.00 -2,266.00 -3,200.00
Sale/Maturity of Investment
53.00 54.00 64.00 104.00 45.00 13.00 27.00 38.00 93.00 392.00 1,196.00 2,250.00 2,666.00 2,127.00 2,947.00
Property, Plant, Equipment (P&PE)
-2.00 -6.00 -8.00 -9.00 -7.00 -16.00 -33.00 -55.00 -66.00 -67.00 -180.00 -199.00 -389.00 -364.00 -236.00
Acquisitions (Net)
- - - - - - - - - - - - - - - - - - -11.00 835.00 - - -30.00 -3.00 - -
Other Investing Activities
- - - - - - 37.00 28.00 - - -17.00 - - -78.00 -61.00 -835.00 -11.00 10.00 -14.00 -17.00
Financing Activities
Used Cash (Net)
-44.00 -69.00 -74.00 -10.00 -11.00 -21.00 -16.00 -8.00 -399.00 -710.00 -10.00 -912.00 -10.00 -552.00 -318.00
Debt Repayment
-1.00 - - - - - - - - -2.00 -2.00 -2.00 -75.00 -836.00 - - -282.00 - - - - -443.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - - - - - - - 110 - - - - - - 580 715
Other Financing Activities
-1.00 - - - - 6.00 12.00 24.00 19.00 8.00 464.00 799.00 -1.00 1,179.00 -9.00 -17.00 -99.00
Cash Balances
Begin of Period
12.00 3.00 4.00 2.00 8.00 43.00 71.00 86.00 94.00 441.00 1,137.00 446.00 818.00 1,053.00 643.00
End of Period
3.00 4.00 2.00 8.00 43.00 71.00 86.00 94.00 441.00 1,137.00 446.00 818.00 1,053.00 643.00 567.00
Change
-9.00 1.00 -2.00 5.00 35.00 28.00 14.00 8.00 347.00 695.00 -690.00 371.00 235.00 -410.00 -75.00
Non-Cash Balances
Depreciation and Amortization
2.00 2.00 3.00 6.00 7.00 8.00 10.00 15.00 16.00 29.00 48.00 67.00 102.00 155.00 186.00
Stock Based Compensation
- - - - 13.00 18.00 24.00 50.00 82.00 110.00 106.00 - - 102.00 119.00 113.00 126.00 150.00
Other
13.00 11.00 -31.00 1.00 3.00 - - 37.00 1.00 17.00 240.00 51.00 93.00 209.00 39.00 -78.00
Highlighted metrics
Free Cash Flow (FCF)
-42.00 -49.00 -38.00 -42.00 -5.00 7.00 15.00 - - 26.00 56.00 134.00 276.00 53.00 304.00 511.00
Cash Conversion Cycle (CCC)
43.00 126.00 108.00 95.00 88.00 40.00 56.00 22.00 - - 4.00 -20.00 121.00 -25.00 -122.00 177.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of DXCM's Analysis
CIK: 1093557 CUSIP: 252131107 ISIN: US2521311074 LEI: - UEI: -
Secondary Listings
DXCM has no secondary listings inside our databases.